CirrhosisRx CDS for Liver Cirrhosis
What You Need to Know Before You Apply
What is the purpose of this trial?
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is CirrhosisRx CDS safe for humans?
How is the CirrhosisRx CDS treatment different from other treatments for liver cirrhosis?
What data supports the effectiveness of the treatment CirrhosisRx CDS for liver cirrhosis?
Who Is on the Research Team?
Jin Ge, MD, MBA
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for adults over 18 years old who have been previously diagnosed with cirrhosis, as confirmed by specific diagnosis codes. It's not open to children, those without a proper cirrhosis diagnosis, or patients who aren't hospitalized.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive care with or without the CirrhosisRx CDS system during hospitalization
Follow-up
Participants are monitored for adherence to quality measures and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- CirrhosisRx CDS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor